Trials / Completed
CompletedNCT02898038
Acceptability and Tolerance Study of a New Oral Nutritional Supplement (ONS)
Tolerance and Acceptability of AYMES PARIS
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- Aymes International Limited · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Tolerance and Acceptability of new oral nutritional supplement - AYMES PARIS
Detailed description
To evaluate tolerance and acceptability of AYMES PARIS in patients requiring supplementary oral nutritional support compared with currently available alternatives, measuring outcomes of GI effects, Compliance, product preference,convenience etc. To obtain data to support an ACBS submissions for AYMES PARIS (to allow for prescription in the community at NHS expense).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | AYMES PARIS | AYMES PARIS is a powdered, high energy, oral nutritional supplement to be mixed with milk as a drink. It provides 320 kcal and 12.2 g protein per 139 ml serving. It is a Food for Special Medical Purposes (FSMP) and must, therefore, be used under medical supervision. It is not designed as a sole source of nutrition. |
Timeline
- Start date
- 2015-11-01
- Primary completion
- 2015-11-01
- Completion
- 2015-11-01
- First posted
- 2016-09-13
- Last updated
- 2016-09-13
Source: ClinicalTrials.gov record NCT02898038. Inclusion in this directory is not an endorsement.